20
NPS Score
VS
NGM Biopharmaceuticals Claimed Company
- EMPLOYEE
PARTICIPANTS - 10
- TOTAL
RATINGS
Verily
- EMPLOYEE
PARTICIPANTS - 18
- TOTAL
RATINGS
NGM Biopharmaceuticals vs Verily
Compare NGM Biopharmaceuticals versus Verily for CEO Rating, Overall Culture Score, Brand Ranking, and other ratings. Results were generated by 10 employees and customers of NGM Biopharmaceuticals and 18 employees and customers of Verily.
NGM Biopharmaceuticals
NGM Biopharmaceuticals's brand is ranked #- in the list of Global Top 1000 Brands, as rated by customers of NGM Biopharmaceuticals. Their current market cap is $280.84M.
Verily
Verily's brand is ranked #- in the list of Global Top 1000 Brands, as rated by customers of Verily.
3.2/5
Product Quality
3.3/5
4.1/5
Pricing
3.6/5
5/5
Customer Service
3.8/5
| 60% | Promoters |
|---|---|
| 0% | Passive |
| 40% | Detractors |
Net Promoter Score
Winner by 20
0
NPS Score
| 42% | Promoters |
|---|---|
| 16% | Passive |
| 42% | Detractors |
See how NGM Biopharmaceuticals compares to its competitors
See how Verily compares to its competitors
Working at NGM Biopharmaceuticals vs Working at Verily
86 / 100
CEO Rating
Winner by 31%
55 / 100
CEO Rating
NGM Biopharmaceuticals
NGM Biopharmaceuticals doesn't have enough ratings to calculate the Team Culture Ratings.
Know someone that works there? Invite them to rate their experience.
Verily
Employees at Verily rate their CEO, Andrew Conrad, 55/100. This score is 31% lower than the scores of NGM Biopharmaceuticals' CEO, David Woodhouse.